We are live on ! Find out more
KP

Kiltearn Partners Portfolio holdings

AUM $372M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
-36.58%
1 Year Est. Return
+18.16%
3 Year Est. Return
+34.48%
5 Year Est. Return
+43.43%
10 Year Est. Return
+168.94%
AUM
$1.5B
AUM Growth
-$1.14B
Cap. Flow
-$155M
Cap. Flow %
-10.3%
Top 10 Hldgs %
58.65%
Holding
27
New
2
Increased
8
Reduced
14
Closed
3

Top Sells

Rank Stock Value
1
KMB icon
Kimberly-Clark
KMB
+$68M
2
JCI icon
Johnson Controls International
JCI
+$58.7M
3
BIIB icon
Biogen
BIIB
+$56.4M
4
OMC icon
Omnicom Group
OMC
+$37.9M
5
GS icon
Goldman Sachs
GS
+$36.3M

Sector Composition

Rank Sector Weight
1 Financials 48.81%
2 Energy 14.59%
3 Healthcare 12.96%
4 Consumer Discretionary 8.19%
5 Communication Services 5.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
1
Goldman Sachs
GS
$289B
$116M 7.71%
750,723
-171,100
-19% -$36.3M
C icon
2
Citigroup
C
$213B
$105M 7%
2,499,651
-157,982
-6% -$10.6M
AMG icon
3
Affiliated Managers Group
AMG
$9.51B
$105M 6.98%
1,776,475
+309,345
+21% +$23.2M
SLB icon
4
SLB Ltd
SLB
$72.7B
$89.1M 5.92%
6,601,984
+1,549,000
+31% +$44.8M
XOM icon
5
ExxonMobil
XOM
$650B
$84.3M 5.6%
2,219,625
+155,300
+8% +$8.58M
WFC icon
6
Wells Fargo
WFC
$254B
$83.6M 5.56%
2,914,337
+601,879
+26% +$25.6M
BEN icon
7
Franklin Resources
BEN
$16.8B
$81M 5.38%
4,850,494
-457,200
-9% -$10.5M
CVS icon
8
CVS Health
CVS
$135B
$79.7M 5.29%
1,342,709
-252,800
-16% -$16.9M
NLSN
9
DELISTED
Nielsen Holdings plc
NLSN
$70.7M 4.7%
5,639,572
+987,524
+21% +$18.5M
MS icon
10
Morgan Stanley
MS
$319B
$67.9M 4.51%
1,997,866
-87,000
-4% -$4.1M
STT icon
11
State Street
STT
$48.4B
$67.2M 4.47%
1,261,900
-58,500
-4% -$4.06M
AXP icon
12
American Express
AXP
$224B
$63.9M 4.25%
746,470
-86,500
-10% -$10.1M
HOG icon
13
Harley-Davidson
HOG
$2.61B
$63M 4.18%
3,325,877
-146,300
-4% -$4.43M
KT icon
14
KT
KT
$8.74B
$59.9M 3.98%
7,701,925
+552,800
+8% +$5.48M
ZBH icon
15
Zimmer Biomet
ZBH
$18.8B
$47.6M 3.17%
485,542
-13,390
-3% -$1.76M
BKR icon
16
Baker Hughes
BKR
$58.3B
$46.3M 3.07%
4,406,900
+1,412,500
+47% +$26.5M
IVZ icon
17
Invesco
IVZ
$12.4B
$44.5M 2.96%
4,904,177
-1,441,500
-23% -$21.9M
AZO icon
18
AutoZone
AZO
$51.3B
$42.5M 2.82%
50,193
-18,216
-27% -$18.9M
UNFI icon
19
United Natural Foods
UNFI
$3.04B
$38.1M 2.53%
4,153,939
-244,700
-6% -$1.94M
LYB icon
20
LyondellBasell Industries
LYB
$19.5B
$35M 2.32%
704,800
+98,800
+16% +$7.27M
WBA
21
DELISTED
Walgreens Boots Alliance
WBA
$34.8M 2.31%
+760,500
New +$38.6M
GILD icon
22
Gilead Sciences
GILD
$165B
$32.9M 2.18%
439,800
-168,900
-28% -$11.7M
OMC icon
23
Omnicom Group
OMC
$23.5B
$28.8M 1.92%
525,219
-534,500
-50% -$37.9M
EBAY icon
24
eBay
EBAY
$51.2B
$17.8M 1.18%
+592,500
New +$20.6M
BIIB icon
25
Biogen
BIIB
$30.9B
-190,200
Closed -$56.4M

Similar funds

Kiltearn Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Kiltearn Partners held 27 positions worth $1.5B, down 43% from $2.65B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Kiltearn Partners withdrew a net $155M in Q1 2020, closing 3 positions and reducing 14 holdings. Its most notable exit was Kimberly-Clark, an estimated $68M position sold in full.

By sector, the portfolio is most concentrated in Financials at 49% of assets, up from 47% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Kiltearn Partners opened a new position in Walgreens Boots Alliance worth $34.8M.

  • Kiltearn Partners's largest Q1 2020 buy was Walgreens Boots Alliance: 760,500 shares worth $34.8M.
  • Kiltearn Partners added most to SLB Ltd in Q1 2020, an estimated $44.8M increase.
  • Kiltearn Partners's biggest Q1 2020 reduction was Omnicom Group, cutting an estimated $37.9M.
  • Kiltearn Partners fully exited Kimberly-Clark in Q1 2020, selling an estimated $68M.
  • Kiltearn Partners's ten largest holdings make up 59% of its $1.5B portfolio in Q1 2020.
  • Kiltearn Partners opened 2 new positions and closed 3 in Q1 2020.
  • Kiltearn Partners's portfolio value fell 43% quarter-over-quarter to $1.5B.

Based on Kiltearn Partners's 13F filing for Q1 2020, filed 14 May 2020.